Literature DB >> 7987846

Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma of the oral cavity.

C L Wu1, P Sloan, A P Read, R Harris, N Thakker.   

Abstract

Loss of heterozygosity indicative of the presence of tumor suppressor genes on chromosome 3p is commonly observed in carcinomas of various tissues. We have examined loss of heterozygosity on chromosome 3p in 27 oral squamous cell carcinomas using 15 highly informative microsatellite polymorphisms and constructed a deletion map of chromosome 3p. Overall, loss of heterozygosity at one or more loci was observed in 14 tumors (approximately 52%). A majority of these tumors (86%) show loss in more than one area. Three distinct regions were identified: 3p13-3p21.1, 3p21.3-3p23, and 3p25. These data suggest a role for at least three tumor suppressor genes on chromosome 3p in oral squamous carcinomas. The regions of deletions overlap with those described for carcinomas of other tissues and parallel those observed in lung carcinomas. This may reflect the common etiology of the two cancers.

Entities:  

Mesh:

Year:  1994        PMID: 7987846

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Differential diagnosis of type 2 neurofibromatosis: molecular discrimination of NF2 and sporadic vestibular schwannomas.

Authors:  C L Wu; N Thakker; W Neary; G Black; R Lye; R T Ramsden; A P Read; D G Evans
Journal:  J Med Genet       Date:  1998-12       Impact factor: 6.318

2.  Characterization of the human beta-catenin gene.

Authors:  A L Norris; A Bailey; J Askham; A Whitehouse; P M Clissold; A F Markham; D M Meredith
Journal:  Mamm Genome       Date:  1996-02       Impact factor: 2.957

3.  Allelic imbalance at chromosome 11 in head and neck squamous cell carcinoma in an Indian patient population.

Authors:  G Mondal; A Tripathi; N Bhattacharya; N Sikdar; A Roy; A Sengupta; B Roy; C K Panda; S Roychoudhury
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

4.  Chromosome 3p loss of heterozygosity and mutation analysis of the FHIT and beta-cat genes in squamous cell carcinoma of the head and neck.

Authors:  M V González; M F Pello; P Ablanedo; C Suárez; V Alvarez; E Coto
Journal:  J Clin Pathol       Date:  1998-07       Impact factor: 3.411

Review 5.  Molecular and cellular biomarkers for field cancerization and multistep process in head and neck tumorigenesis.

Authors:  V A Papadimitrakopoulou; D M Shin; W K Hong
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

6.  Chromosome 3 allelic losses and microsatellite alterations in transitional cell carcinoma of the urinary bladder.

Authors:  M Li; Z F Zhang; V E Reuter; C Cordon-Cardo
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

7.  Gene expression alterations over large chromosomal regions in cancers include multiple genes unrelated to malignant progression.

Authors:  Brett G Masayesva; Patrick Ha; Elizabeth Garrett-Mayer; Thomas Pilkington; Rong Mao; Jonathan Pevsner; Traci Speed; Nicole Benoit; Chul-So Moon; David Sidransky; William H Westra; Joseph Califano
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-20       Impact factor: 11.205

Review 8.  Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature.

Authors:  Christa Lese Martin; Shalini C Reshmi; Thomas Ried; William Gottberg; John W Wilson; Jaya K Reddy; Poornima Khanna; Jonas T Johnson; Eugene N Myers; Susanne M Gollin
Journal:  Oral Oncol       Date:  2007-08-02       Impact factor: 5.337

9.  FHIT gene alterations in head and neck squamous cell carcinomas.

Authors:  L Virgilio; M Shuster; S M Gollin; M L Veronese; M Ohta; K Huebner; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

10.  Loss of heterozygosity on chromosomes 3p,8p,9p and 17p in the progression of squamous cell carcinoma of the larynx.

Authors:  Woo Jeong Yoo; Seung Ho Cho; Youn Soo Lee; Gyeong Sin Park; Min Sik Kim; Byung Kee Kim; Won Sang Park; Jung Yong Lee; Chang Suk Kang
Journal:  J Korean Med Sci       Date:  2004-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.